Observations of time-based measures of flow-mediated dilation of forearm conduit arteries: Implications for the accurate assessment of endothelial function

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 299, Issue 3, 2010, Pages

  Liuni, Andrew ^a,b   Luca, Mary Clare ^a,b   Lisi, Monica ^c   Dragoni, Saverio ^c   Di Stolfo, Giuseppe ^c   Mariani, Justin A ^a   Uxa, Amar ^a   Gori, Tommaso ^c,d   Parker, John D ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HOSPITAL OF SIENA   (Italy)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Arterial diameter; Endothelium; Flow mediated dilation; Time to peak dilation; Vascular physiology

Indexed keywords

N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER;

ADULT; AGED; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; FOREARM; HEART FAILURE; HUMAN; HYPEREMIA; HYPERTENSION; MALE; MIDDLE AGED; PRIORITY JOURNAL; REPRODUCIBILITY; SMOKING; ADOLESCENT; ANALYSIS OF VARIANCE; BLOOD FLOW; BRACHIAL ARTERY; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BRACHIAL ARTERY; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NG-NITROARGININE METHYL ESTER; REGIONAL BLOOD FLOW; SMOKING; VASODILATION;

EID: 77956706068     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00271.2010     Document Type: Article

References (29)

1. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26: 1235-1241, 1995.
2. Balligand JL, Feron O, Dessy C. eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol Rev 89: 481-534, 2009.
3. Black MA, Cable NT, Thijssen DH, Green DJ. Importance of measuring the time course of flow-mediated dilatation in humans. Hypertension 51: 203-210, 2008.
4. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310, 1986. (Pubitemid 16134762)
5. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111-1115, 1992.
6. Chironi G, Craiem D, Miranda-Lacet J, Levenson J, Simon A. Impact of shear stimulus, risk factor burden and early atherosclerosis on the time-course of brachial artery flow-mediated vasodilation. J Hypertens 26: 508-515, 2008.
7. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39: 257-265, 2002.
8. Craiem D, Chironi G, Gariepy J, Miranda-Lacet J, Levenson J, Simon A. New monitoring software for larger clinical application of brachial artery flow-mediated vasodilatation measurements. J Hypertens 25: 133-140, 2007. (Pubitemid 44885674)
9. Donald AE, Halcox JP, Charakida M, Storry C, Wallace SM, Cole TJ, Friberg P, Deanfield JE. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol 51: 1959-1964, 2008.
10. Doshi SN, Naka KK, Payne N, Jones CJ, Ashton M, Lewis MJ, Goodfellow J. Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide. Clin Sci (Lond) 101: 629-635, 2001.
11. Dragoni S, Di Stolfo G, Sicuro S, Lisi M, Parker JD, Forconi S, Gori T. Postconditioning fails to prevent radial artery endothelial dysfunction induced by ischemia and reperfusion: evidence from a human in vivo study. Can J Physiol Pharmacol 84: 611-615, 2006.
12. Dragoni S, Gori T, Di SG, Sicuro S, Forconi S, Parker JD. Folic acid does not limit endothelial dysfunction induced by ischemia and reperfusion: a human study. J Cardiovasc Pharmacol 46: 494-497, 2005. (Pubitemid 41407579)
13. Ghiadoni L, Donald AE, Cropley M, Mullen MJ, Oakley G, Taylor M, O'Connor G, Betteridge J, Klein N, Steptoe A, Deanfield JE. Mental stress induces transient endothelial dysfunction in humans. Circulation 102: 2473-2478, 2000.
14. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Menzoian JO, Vita JA. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study. Circulation 105: 1567-1572, 2002.
15. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, Vita JA. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 41: 1769-1775, 2003.
16. Gori T, Burstein JM, Ahmed S, Miner SE, Al-Hesayen A, Kelly S, Parker JD. Folic acid prevents nitroglycerin-induced nitric oxide synthase dysfunction and nitrate tolerance: a human in vivo study. Circulation 104: 1119-1123, 2001.
17. Gori T, Di Stolfo G, Sicuro S, Dragoni S, Lisi M, Forconi S, Parker JD. Nitroglycerin protects the endothelium from ischaemia and reperfusion: human mechanistic insight. Br J Clin Pharmacol 64: 145-150, 2007. (Pubitemid 47063243)
18. Gori T, Dragoni S, Lisi M, Di Stolfo G, Sonnati S, Fineschi M, Parker JD. Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function. J Am Coll Cardiol 51: 1953-1958, 2008.
19. Gori T, Grotti S, Dragoni S, Lisi M, Di Stolfo G, Sonnati S, Fineschi M, Parker JD. Assessment of vascular function: flow-mediated constriction complements the information of flow-mediated dilatation. Heart 96: 141-147, 2010.
20. Gori T, Sicuro S, Dragoni S, Donati G, Forconi S, Parker JD. Sildenafil prevents endothelial dysfunction induced by ischemia and reperfusion via opening of adenosine triphosphate-sensitive potassium channels: a human in vivo study. Circulation 111: 742-746, 2005.
21. Hayoz D, Drexler H, Munzel T, Hornig B, Zeiher AM, Just H, Brunner HR, Zelis R. Adaptive and maladaptive processes: flow-mediated dilation is abnormal in congestive heart failure. Circulation 87: 92-96, 1993.
22. Jin ZG, Ueba H, Tanimoto T, Lungu AO, Frame MD, Berk BC. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ Res 93: 354-363, 2003.
23. Mullen MJ, Kharbanda RK, Cross J, Donald AE, Taylor M, Vallance P, Deanfield JE, MacAllister RJ. Heterogenous nature of flow-mediated dilatation in human conduit arteries in vivo: relevance to endothelial dysfunction in hypercholesterolemia. Circ Res 88: 145-151, 2001.
24. Nabel EG, Selwyn AP, Ganz P. Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. J Am Coll Cardiol 16: 349-356, 1990. (Pubitemid 20245851)
25. Palinkas A, Toth E, Venneri L, Rigo F, Csanady M, Picano E. Temporal heterogeneity of endothelium-dependent and -independent dilatation of brachial artery in patients with coronary artery disease. Int J Cardiovasc Imaging 18: 337-342, 2002.
26. Pyke K, Green DJ, Weisbrod C, Best M, Dembo L, O'Driscoll G, Tschakovsky M. Nitric oxide is not obligatory for radial artery flow-mediated dilation following release of 5 or 10 min distal occlusion. Am J Physiol Heart Circ Physiol 298: H119-H126, 2010.
27. Pyke KE, Dwyer EM, Tschakovsky ME. Impact of controlling shear rate on flow-mediated dilation responses in the brachial artery of humans. J Appl Physiol 97: 499-508, 2004.
28. Vita JA, Keaney JF Jr. Endothelial function: a barometer for cardiovascular risk? Circulation 106: 640-642, 2002. (Pubitemid 34851918)
29. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42: 1149-1160, 2003.